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1. Literature review 
Epidemiology of colorectal cancer  
          Incidence and mortality  
More than one million individuals worldwide will develop colorectal cancer (CRC), which 
accounts for more than 9% of all new cancers annually (1). CRC is the third most common 
cancer in males and the second most common cancer in females worldwide (2). The majority 
of CRC is categorized as adenocarcinoma (90%), with the remaining 10% including adeno 
squamous, squamous cell , neuroendocrine, spindle cell and undifferentiated carcinomas (3). 
The incidence varies geographically, with a 10-fold difference between regions. Notably, 
55% of the cases occur in high income countries (HICs) (2). Australia, New Zealand, Europe, 
and Northern America have the highest incidence rates of CRC. On the other hand, Africa, 
South-Central America, and South-Central Asia have lower incidence rates (4) . For both 
sexes, the crude incidence of CRC in Sub-Saharan Africa (SSA) was reported to be 4.04 per 
100,000 population (5). However, the mortality rate in HICs has noticeably declined (6,7), 
while it has not in low- and middle-income countries (LMICs)(2). The 5-year survival rate 
was 8.3% in Uganda (8) and 17.4% in Zimbabwe (9), compared with 59% in England and 
Wales.(10) A low incidence of CRC in South Africa (SA) has been reported, although it has 
increased over the past decade. In 1989, CRC was the 10th most common cancer diagnosed 
in males and females (11). Currently, CRC is the fourth  most common cancer among both  
women and  men in SA. In 2014, as reported by National Cancer Registry, the gross 
incidence rate was 7.34 per 100,000 per year for men and 5.80 per 100,000 per year for 
women (12).  
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Risk factors  
Historically, genetic and environmental factors influence the epidemiology of CRC. Age is a 
known risk factor for CRC. Most often, CRC presents in individuals over the age of 50 years  
(13). Furthermore, gender and race impacts CRC incidence with women and people of colour 
having a lower incidence than men and white people respectively (14), although this may be 
confounded by access to care.   
CRC incidence increases with economic development. CRC incidence rates have increased in 
economically transitioning countries, whereas rates have stabilized or decreased in 
economically developed countries. This increase in economically transitioning countries may 
reflect the adoption of the Western lifestyles and behaviours, for example, low-fibre diet, 
animal fat, red meat, and alcohol consumption, and sedentary lifestyle are be risk factors 
(15,16). On the other hand, fruit and vegetable consumption, nonsteroidal anti-inflammatory 
drugs (NSAIDs), hormone replacement therapy, and physical activity are protective factors  
(15–17).   
Alcohol consumption is a contributing factor to colon carcinogenesis. When comparing 
moderate alcohol consumption (2-3 units per day) and higher alcohol consumption with light 
alcohol consumption, risk for CRC increases by 20% and 50% respectively (18). Seitz & 
Mueller found that when alcohol enters the colon, it is microbially metabolized as 
acetaldehyde. This in turn damages the folate, which is responsible for DNA synthesis and 
the repair of cells, which increases the risk of developing mucosal dysplasia (19).   
Furthermore, cigarette smoking has been found to increase the risk of developing colorectal 
adenomas by two to three fold. This is because the gastrointestinal tract and circulatory 
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system spreads the cigarette carcinogens to the colorectal mucosa, increasing the risk of 
inflammation, mutagenesis, and carcinogenesis (20).  
  
Up to 20% of individuals with CRC have other family members who have been impacted by 
this illness. (21).The explanations for the increased risk are not well explained but are 
possibly due to hereditary genes, shared environmental factors, or a mixture of both (21).  
However, most CRCs are sporadic, as three-quarters of patients have a negative family 
history (22, 23). Hereditary colorectal cancers related to familial adenomatous polyposis 
(FAP) and hereditary colorectal cancer (HNPCC) account for 10% of CRC. People with these 
genetic mutations will have an 80% lifetime risk. Indeed, those affected by a hereditary  
CRC form a specific sub-group of the patient population, representing 5–10% of all patients.  
HNPCC is the most prevalent (24).  
  
Anatomic distribution of colorectal cancer  
  
  
Historically, two-thirds of CRC cases are found in the left colon (descending colon and 
sigmoid colon), and rectum and one-third in the right colon (cecum, ascending colon, hepatic 
flexure, transverse colon, splenic flexure,) (25, 26). However, there are recent 
epidemiological studies in HICs that report a trend of a right shift of CRC (27–29).  
  
It is still unclear whether this right colonic shift occurred due to environmental and genetic 
factors or a change in screening protocols. Flexible sigmoidoscopy can detect left colonic and 
rectal lesions while right colonic lesions can only be found during a colonoscopy, which 
requires more advanced practitioner training as well as bowel preparation (30,31). For 
example, flexible sigmoidoscopy can be conducted by a general practitioner and only 
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requires a rectal enema, whereas a colonoscopy is usually done by a gastroenterologist or 
surgeon and requires oral bowel preparation. Increased use of colonoscopy may be a reason 
for the increase in right lesions detected. However, different distributions of colorectal 
tumours between the right, left colon and rectum might be due to environmental risk factors 
such as diet and lifestyle, different frequencies of hereditary colorectal neoplasms (which are 
characterized by increased frequency in the right colon). In addition, it has been suggested 
that the different embryological origins of the right and left colon provide distinct molecular 
patterns, which results in variable susceptibility to CRC  (32).  
  
In HICs, right  colon tumour incidence has increased while left colon and rectum incidence 
has decreased (33). Migration of individuals from LMICS to HICs countries has changed the 
epidemiology of the anatomical distribution. As migrants are exposed to the environmental 
factors, they are at risk of developing CRC (34, 35). Notably, these migrants tend to develop 
CRC in the left colon (34–36) .There is an association between tumour location and dietary 
factors, as it has been observed that a high intake of fat increases the risk of right colonic 
lesions while a high intake of protein increases the incidence of left colonic and rectal lesions 
(37,38).  
  
There are variations in anatomic distribution by gender in many HICs. For example, New 
Zealand has a difference in anatomic distribution incidence by gender. Men tended to have 
rectal cancer, while women had more right colonic lesions (39). Anatomic distribution is also 
associated with age. In the US, right colonic lesions (proximal to the splenic flexure) 
increased with age (40,41). However, a longitudinal study done in the United Kingdom 
between 1993 and 2002, including 763 patients with adenocarcinoma, showed no evidence of 
a shift towards the right colon when considering age and gender at the time of the diagnosis  
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(42).   
  
In the United States of America (US), older individuals, particularly whites and African 
Americans, have been shown to experience the highest CRC burden especially right colonic 
lesions (43). In the US, there has been a shift in incidence towards right colonic lesions; this 
may be explained by increased screening using colonoscopy to examine the entire colon, 
including the right area, and with population ageing (43).  
  
Japan has shown a similar trend as in the US, with rising right incidence compared with rectal 
cancer (44). Additionally, a recent cohort study compared the prevalence, shape, and location 
of colorectal neoplasia between South Korean and American patients. Among South Korean 
patients, there were adenomas and advanced tumours in the left colon and rectum, but a lower 
risk of right colonic neoplasia compared with American patients (45).  
  
In South-East Asia, specifically Malaysia, tumours were mainly located in the left colonic 
and rectum side. There were no variations in anatomical location between races, sexes and 
age groups (46). In Africa, the data on the anatomical distribution of CRC are not well 
investigated. Some countries have carried out a small number of studies; however, due to the 
limited resources and screening programs available, these studies are limited (5) . Rectal 
cancer is still a predominant distribution of colorectal cancer in SSA, accounting for 46%, 
followed by the cecum at 17% (5). Nigeria, with the highest population in Africa, has 
experienced an increase in the incidence of CRC in both urban and rural areas. In a review 
between 1991-2000 by the Jos University Teaching Hospital, it was reported that CRC was 
located predominantly in the rectum (57%), followed by the colon (32%) and the cecum (8%) 
(47). In 2013, data in rural Nigeria showed that the subsites of CRC were predominantly in 
the right side, mainly in the cecum (36%) and the hepatic flexure (21%), followed by the 
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rectum (24%) (48). However, the right colonic shift of CRC was not observed in Sudan, as 
83% of CRC patients had lesions in the rectosigmoid region and only a minority had right 
colonic tumours (49).   
  
In South Africa, there are few studies reporting the prevalence and incidence or anatomic 
distribution of CRC. In the Northern Cape, it was reported that the right colon was the 
dominant location for CRC among people younger than 50 years old. This was caused mainly 
by inherited diseases, such as HNPCC also known as Lynch syndrome and the microsatellite 




In South Africa, a developing country, CRC has started to become a major challenge for 
patients and surgeons as it is the third most common cancer in women and the fourth most 
common cancer in men (12).  The right colonic shift in CRC has occurred in some African 
countries (48). However, there is not sufficient data about the incidence, age group, and 
anatomical distribution of CRC in South Africa. This study reports the incidence, age group, 
and anatomical distribution of CRC between 2006 to 2010. The results of this study may  
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Background: Colorectal cancer (CRC) is the 5th most common cancer in sub- Saharan 
Africa (SSA) and the 3rd most common cancer in Southern Africa. CRC 
characteristics in SSA, including anatomic distribution, are not well described.  
  
Objective: To describe patient characteristics and anatomic location of colorectal 
adenocarcinoma (CRC-AC) in South Africa.  
  
Design: This was a retrospective study of CRC using the South African National  
Cancer Registry from 2006-2011.  
  
Main Outcome Measures: Patient age, gender, racial/ethnic group, province, histology 
type, and tumour location.  
  
Results: 6146 patients were included in the analysis. Among patients with adenocarcinomas, 
the median age of presentation was 60 (interquartile range, 49-70) years. 1372 (25%) of 
patients were < 50 years and 2870 (52%) were male. There were 5498 (89%) cases of 
adenocarcinoma (AC). 1277 (26%) CRC-AC were right colonic lesions, 1214 (25%) were 
left colonic lesions, and 2404 (49%) lesions were located in the rectum. Patients ≥ 50 years at 
presentation (OR=1.29. p<0.001) and from Limpopo province (OR=1.46, p=0.029) were 
more likely to have left colonic and rectal adenocarcinoma on multivariate analysis. Patients 
who were black (OR=1.67, p<0.001), had right colonic lesions (OR=1.25, p=0.007), and 
were from Mpumalanga (OR=1.67, p=0.007), Limpopo (OR=1.60, p=0.002), or Northwest 
(OR=1.76, p=0.001), were significantly associated with early onset adenocarcinoma.   
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Conclusion: CRC-AC in South Africa presents at an earlier age than in HICs, such as the US.  
Early-onset CRC is higher in black South Africans who live in Mpumalanga, Limpopo, and 
Northwest in comparison with other provinces. The majority of colorectal cancer were left-
sided and rectal; thus screening flexible sigmoidoscopy should be considered. Further studies 












Colorectal cancer (CRC) is the 5th most common cancer in sub-Saharan Africa (SSA) and the 
3rd most common cancer in Southern Africa (1). Adenocarcinoma (AC) accounts for the vast 
majority of cases (2,3).  The incidence of CRC in SSA is lower than in high-income countries 
(HICs) (4).This may be due to variations in genetic factors and environmental factors such as 
nutrition, obesity and rates of exercise (5,6). Additionally, differences in life expectancy and 
access to diagnostics and screening between SSA and HICs may influence the variation seen 
between regions. For example, South Africa and the United States of America (US) have a 16 
year difference in life expectancy (7). Given that colorectal cancer often develops over the age 
of 50 years (8), South Africa’s lower life expectancy and limited access to screening programs 
may impact incidence rates. Furthermore, gender and race impacts CRC incidence with women 
and people of colour having a lower incidence than men and white people respectively (9), 
although this may be confounded by access to care. While CRC incidence is lower in SSA than 
HICs, more than two-thirds of people with CRC in low- and medium- human development 
index (HDI) countries die compared with approximately half in high HDI. (10–12).   
  
CRC is distributed throughout the colon and rectum and can be classified into right colonic, 
left colonic, and rectal lesions. Right colonic lesions are found in the cecum, right colon (or 
ascending), hepatic flexure, and transverse colon. Left colonic lesions are located on the splenic 
flexure, left (or descending) and the sigmoid colon. Rectal lesions are located in the 
rectosigmoid or rectum (13–16). In the US, the majority of lesions were historically found in 
the rectum and the left colon, however, a right colonic shift, especially in older patients, has 
been noted (17). In SSA, results have been varied. Preliminary results in South Africa from one 
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urban centre has reported that left colonic and rectal adenocarcinoma in two- thirds of patients, 
which included 43% of rectal lesions (18). In Nigeria, 60% of CRC were located in the rectum  
(4)  and in Tanzania, 60% of lesions were in the left colon (19) .   
  
Different tumour locations in the colon are likely to have a different pathogenesis  (20). Two 
CRC pathways involving mismatch repair (MMR) genes preferentially affect the right colon. 
The first is microsatellite instability (MSI) from MMR mutations and is associated with 
younger patients and hereditary non-polyposis colon cancer (HNPCC) (21). The second is 
hypermethylation of the MMR gene which is a sporadic pathway associated with serrated 
polyps and older patients (22). Left colon cancers are usually caused by chromosomal 
instability of oncogenes or tumour suppressor genes and can be sporadic or hereditary (23).   
  
The anatomic distribution of CRC has implications for screening and treatment. Currently, 
there is debate on the best screening method for CRC. While colonoscopy has been the gold 
standard in the US, it has risks and usually requires a specialist (surgeon or gastroenterologist) 
to perform the procedure. In South Africa, an upper-middle income country, screening 
colonoscopy is not readily available in the public (government) sector, which provides health 
care to the majority of the population(24). Left colonic and rectal adenocarcinoma  are the most 
common, compared with right colonic lesions (18). Flexible sigmoidoscopy, which is used to 
detect left colonic and rectal adenocarcinoma, could potentially be used as a screening tool, 
particularly because the procedure does not require sedation and can be performed by non- 
specialists.   
  
Anatomic distribution can also vary based on age and race. Understanding the racial/ethnic 
disparities in the anatomic distribution would also have implications for early diagnosis and 
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treatment. In the US, the median age at presentation is 70 years (25). However, African 
Americans are being diagnosed with CRC at a younger age (< 50 years old), but with lower 
survival than whites (26,27). Therefore, earlier screening is recommended starting at the age of 
40 years (28).  CRC in SSA presents at a younger median age than in the US. There are also 
racial/ethnic differences, with black Africans presenting at a younger age than whites (18)(29–
32). Furthermore, although left colonic and rectal adenocarcinoma are more common in SSA 
(33), among patients with right colonic lesions, a report from Zimbabwe showed that blacks 
had a high proportion of right lesions compared with whites especially in younger patients (29). 
In a regional South African study, blacks <50 years of age with CRC presented with a higher 
proportion of right colonic lesions and microsatellite instability compared with white patients 
(16).  
  
There have not been any nationwide studies on the anatomic distribution of colorectal cancer 
in South Africa. The main objective of this study was to describe the anatomic distribution of  
CRC adenocarcinoma in South Africa using the South African National Cancer Registry 
(SANCR). The secondary objectives were to describe associations with early-onset cancer and 




Study design and period  
The SANCR was established in 1986 and collects all pathology-diagnosed cancers in the  
South African population (histology, cytology, and bone marrow aspirate and trephines) (34).  
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This was a retrospective study of all pathology-confirmed CRC reported to the SANCR from 
2006-2011. During the study period, the SANCR only captured public (government) sector 
specimens.  
  
Study population  
All patients who had CRC confirmed tumour specimens submitted to SANCR were included. 
Patients with CRC but whose pathology specimens were not submitted to SANCR were 
excluded. In addition, patients without pathology reports on primary CRC (i.e. metastatic 
disease) were excluded.  
  
Data analysis  
A dataset from the SANCR for all CRC specimens for the study period were obtained. The 
SANCR database was established in 1986 and through 2011, included all pathology proven 
cancers from the public sector. The SANCR Methodology follows the recommendations by the 
International Agency for Research on Cancer (IARC). Pathology reports were received in 
electronic or hard copy format, from which appropriate data items, namely demographics and 
tumour information were abstracted. A hot-deck imputation method was used to allocate 
population groups to cases without this information (35). Following international practice,  
CRC cancers were classified by anatomical site/topography using the International 
Classification of Diseases – Oncology, Version 3 (ICD-O-3)  (36). Cases of confirmed CRC as 
coded by the SANCR coders (ICD 0 classification C18.0 to C20.9) were selected by the 
SANCR to be included in this study. Full pathology reports were anonymized then shared with 
the authors. Variables from SANCR included age, gender, province, race, ICD.10 code, and 
the full pathology report were extracted.   
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For this study, entries codes as ICD10 18.0-18.9 were extracted. The full pathology reports 
were read by one of several authors to confirm the anatomic location of the lesion (right, left, 
or rectum, unknown/other, non-primary) and the type of CRC (adenocarcinoma, carcinoid, 
lymphoma, squamous cell carcinoma, other). Patients who had multiple biopsies were 
included only once. Non-primary specimens were excluded. Patients with an unknown 
anatomic location were excluded from the analysis for location. Similar to previous studies, 
(15,16,37,38). Lesions in the cecum, ascending colon, hepatic flexure, transverse colon, and 
splenic flexure were defined as right colonic lesions. Lesions in the descending colon, and 
sigmoid were defined as left colonic lesions. Lesions in the rectosigmoid and rectum were 
defined as rectal lesions. All patients were initially classified by tumour type, however, the 
analysis on associations with the location of the tumour was only done on CRC 
adenocarcinomas (AC). Patients <50 years of age at presentation were defined as early-onset 
cancer. Data were analysed using Stata 15 (College Park, Texas USA). Univariate and 
multivariate analysis was performed to determine associations with location. Variables with a 
p-value ≤ 0.10 were included in the multivariate analysis. All data were anonymized, and the 
master data list is held by the SANCR. Ethics approval was given by the University of Cape  




There were 6246 patients with CRC; 100 had non-primary specimens, leaving 6146 patients 
for analysis. Table 1 illustrates the patient characteristics, histologic type, and anatomic 
location of the cancers. There were 5498 (89%) cases of AC. Among cases of AC, the median 
age of presentation was 60 (interquartile range (IQR), 49-70) years. It was found that 1372 
(25%) patients were <50 years and 2870 (52%) were male. There were 4895 cases of known 
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anatomic location and 1277 (26%) of CRC-AC were right whilst 1214 (25%) were left and 
2404 (49%) were located in the rectum. Anatomic location by age group are shown in Table 2. 
In patients <50 years of age, 26% of all adenocarcinomas were right-sided compared with 22% 
in patients ≥50 years (p=0.006).  
  
Associations with Left Colonic and Rectal Adenocarcinoma  
Patients ≥50 years of age at presentation (OR=1.29, p<0.001), and from the Limpopo province 
(OR=1.46, p=0.029) were more likely to have left colonic and rectal adenocarcinoma on 
multivariate analysis (see Table 3).  
  
Associations with Early Onset Colorectal Adenocarcinoma  
Patients who were black (OR=1.67, p<0.001), had right colonic lesions (OR=1.25, p=0.007) or 
were from Mpumalanga (OR=1.67, p=0.007), Limpopo (OR=1.60, p=0.002), or the Northwest 
(OR=1.76, p=0.001) provinces were more likely to be <50 years of age at presentation on 
multivariate analysis (see Table 4). Patients who were white were less likely to develop early 




This is the first study of CRC in South Africa using the national cancer registry data. The 
majority of CRC were adenocarcinomas. The median age of presentation was 60 years 
compared with 67 years in the US (39). One-quarter of patients were under 50 years of age. 
This may be influenced by South Africa’s relatively lower life expectancy, genetic variation, 
and cultural/ environmental factors. More research is needed to understand why patients are 
presenting at a relatively younger age in South Africa.   
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Inherited cancers such as HNPCC are known to affect large cohorts of families in South Africa. 
In the Northern Cape, families with 13 different germline mismatch repair gene mutations have 
been identified with over 1500 at-risk individuals (40)(41). The specific mutation is unknown, 
therefore, these higher risk individuals undergo screening colonoscopy annually (36). 
However, in our study, a multivariate analysis revealed the Northern Cape province was not 
significantly associated with early-onset adenocarcinoma. It is possible that inherited cancers 
such as HNPCC are also prevalent in these provinces, but more epidemiologic and genetic 
studies are needed. In our study, black South Africans were more likely to present with early-
onset cancer than other population groups. This is consistent with studies from other SSA 
countries as well as the US (16)(42). In contrast, this study revealed white patients were less 
likely to develop early onset adenocarcinoma than other population groups. Less global data 
on black people and CRC are available compared to data on white people. More research is 
need around risk factors for early onset adenocarcinoma including understanding tumour 
biology and social determinants. In our study right colonic lesions were associated with early 
onset adenocarcinoma. In other studies, right sided colonic lesions have been associated with 
hereditary CRC such as HNPCC (43,44), but this study did not distinguish between sporadic 
and hereditary cases.  
  
The difference in incidence rates between right, left, and rectal colonic lesions may be 
influenced by accessibility of diagnostic tools. Left colonic and rectal adenocarcinoma are often 
diagnosed with a flexible sigmoidoscopy, which doesn’t require sedation and can be done by a 
general practitioner compared with right colonic lesions which require the use of a 
colonoscopy. However, given the fact that left colonic and rectal adenocarcinoma accounted 
for nearly three-quarters of CRC-AC and were associated with older age in our study, flexible 
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sigmoidoscopy would  detect the majority of colonic and rectal lesions in South Africa and 
should be considered as part of public health screening, especially in persons older than 50 
years.   
  
This study has limitations. Unlike other national registries such as Surveillance, Epidemiology, 
and End Results (SEER) in the US and the Sweden Cancer Register, the SANCR is only based 
on registered pathologic specimens does not capture stage at presentation or outcomes such as 
mortality (45,46). Single institutions databases such as Groote Schuur Hospital have 
prospective databases with stage and survival data, but a South African national registry that 
captures these variables is needed as well. Furthermore, data from the private sector were not 
available. Sixteen percent of South Africans have private health insurance, especially among 
white South Africans (47). Without data from the private sector, the results of the study cannot 
be generalized to be representative of the whole of South Africa.  
  
In conclusion, CRC-AC in South Africa presents at an earlier age than in HICs, such as the  
US. There are disparities with early-onset CRC. Early-onset CRC is higher in black South 
Africans who live in Mpumalanga, Limpopo, and Northwest in comparison with other 
provinces. The majority of CRC were left colonic and rectal tumours and screening flexible 
sigmoidoscopy should be considered. Further studies on the age-specific incidence and the 




Tables and Figures  
 
Table 1: Demographic and Histological Characteristics of Colorectal Cancer in South Africa (2006-2011) 
 
 Characteristics  All Colorectal Cancers Adenocarcinomas 
  N (%) N (%) 
Total Number  6146 (100) 5498 (100) 
Gender      
Male  3182 (51.8) 2870 (52.2) 
Race       
Black  2680 (43.6) 2359 (42.9)  
Mixed Race  1233 (20.1)  1130 (20.5)  
White  1834 (29.8)  1650 (30.0)  
Indian/Asian  134 (2.2)  120 (2.2)  
Missing  265 (4.3)  237 (4.3)  
Age Group      
<20  33 (0.5) 25 (0.4) 
20–29  206 (3.3)  181 (3.3) 
30–39  435 (7.1)  369 (6.7) 
40–49  908 (14.8)  797 (14.5) 
50–59  1373 (22.3)  1224 (22.3) 
60–69  1520 (24.7)  1386 (25.2) 
70–79  1134 (18.4)  1015 (18.5) 
≥80  415 (6.7)  385 (7.0) 
Missing  122 (2.0)  116 (2.1) 
Provinces      
Eastern Cape  766 (12.5)  725 (13.2)  
Northern Cape   158 (2.6)  148 (2.7)  
Western Cape  2121 (34.5)  1977 (36.0)  
Free State   429 (7.0)  376 (6.8)  
Gauteng  1935 (31.5)  1595 (29.0)  
Mpumalanga  162 (2.6)  146 (2.7)  
Limpopo  295 (4.8)  278 (5.1)  
Kwa-Zulu Natal  65 (1.1)  59 (1.1)  
Northwest   215 (3.5)  194 (3.5)  
Year of Diagnosis      
2006  835 (13.6)  744 (13.5)  
2007  969 (15.8)  873 (15.9)  
2008  958 (15.6)  853 (15.5)  
2009  1106 (18.0)  993 (18.1)  
2010  1092 (17.8)  974 (17.7)  
2011  1186 (19.3)  1061 (19.3)  
Histologic types      
Adenocarcinomas  5498 (89.5)  5498 (100)  
Squamous cell carcinoma  91 (1.9)    
Carcinoid  3 (0.05)    
Other/Unknown  554 (9.0)    
Colon cancer site  n=5413a  n=4895b  
Right    1479 (27.3)  1277 (26.1)  
Left   1302 (24.0)  1214 (24.8)  
Rectum  2632 (48.6)  2404 (49.1)  




Table 2: Anatomic Distribution of Colorectal Adenocarcinoma by Age Group in South 
Africa (2006-2011)  
  
  Right   Left   Rectal  Totala  
Age group   N (%)  N (%)  N (%)  N (%)  
<20  2 (10.5)  2 (10.5)  15 (78.9)  19(100)  
20-29  38 (23.8)  20 (12.5)  102 (63.8)  160 (100)  
30-39   102 (31.8)  73 (22.7)  146 (45.5)  321 (100)  
40-49  215 (30.6)  175 (24.9)  312 (44.4)  702 (100)  
50-59  313 (28.4)  258 (23.4)  530 (48.1)  1101 (100)  
60-69  293 (23.6)  336 (27.0)  612 (49.3)  1241(100  
70-79  208 (22.7)  237 (25.9)  471 (51.4)  916 (100)  
≥80  83 (24.0)  95 (27.5)  167 (48.4)  345 (100)  
Missing age  23 (25.6)  18 (20.0)  49 (54.4)  90 (100)  





Table 3: Associations with Left Colonic and Rectal Adenocarcinoma in South Africa (2006-
2011)  
  
  Univariate analysis Multivariate analysis 
  OR 95% Cl P value OR 95% Cl P value 
Age group              
≥50 years  1.27  (1.10-1.47)  0.001 1.29  (1.11-1.50)  <0.001 
Gender            
Male  0.92  (0.81-1.05)  0.225      
Race            
Blacks  1.03  (0.90-1.17)  0.675      
Mixed Race  0.91  (0.79-1.07)  0.276      
Whites  1.02  (0.89-1.17)  0.755      
Indians/Asian  1.33  (0.83-2.11)  0.232      
Missing  0.94  (0.68-1.28)  0.682      
Year of Diagnosis            
2006  1.10  (0.91-1.34)  0.314      
2007  0.99  (0.83-1.18)  0.945      
2008  0.91  (0.77-1.09)  0.335      
2009  1.06  (0.88-1.22)  0.680      
2010  1.07  (0.91-1.27)  0.413      
2011  0.91  (0.78-1.07)  0.269      
Provinces            
Eastern Cape  1.19  (0.98-1.45)  0.068 1.16  (0.95-1.43)  0.150 
Northern Cape   0.88  (0.59-1.30)  0.520      
Western Cape  0.87  (0.76-0.99)  0.036 0.91  (0.79-1.04)  0.180 
Free State   0.89  (0.70-1.14)  0.363      
Gauteng  1.02  (0.88-1.18)  0.729      
Mpumalanga  1.03  (0.69-1.55)  0.853      
Limpopo  1.42  (1.02-1.98)  0.035 1.46  (1.04-2.05)  0.029 
Kwa-Zulu Natal  0.88  (0.46-1.60)  0.626      
Northwest   1.15  (0.80-1.67)  0.438      





Table 4: Associations with Early Onset Adenocarcinoma in South Africa (2006-2011)  
  
  Univariate analysis Multivariate analysis 
  OR 95% CI P value OR 95% CI P value 
Gender              
Male   0.92  (0.81-1.03)  0.156      
Race            
Black  2.17  (1.92-2.46)  <0.001 1.67  (1.39-2.02)  <0.001 
Mixed Race   0.91  (0.78-1.06)  0.218      
White  0.42  (0.36-0.49)  <0.001 0.55  (0.45-0.67)  <0.001 
Indian/Asian   0.56  (0.34-0.92)  0.021 0.66  (0.38-1.13)  0.125 
Missing  0.90  (0.66-1.23)  0.525      
Colon Cancer  
Site   
          
Right   1.27  (1.10-1.47)  0.001 1.25  (1.06-1.46)  0.007 
Left   0.84  (0.72-0.98)  0.031 0.91  (0.76-1.07)  0.240 
Rectum  0.91  (0.80-1.06)  0.118      
Year of Diagnosis            
2006  1.04  (0.80-1.06)  0.693      
2007  0.96  (0.76-1.2)  0.713      
2008  1.02  (0.81-1.28)  0.866      
2009  0.94  (0.76-1.18)  0.611      
2010  1.01  (0.81-1.25)  0.951      
2011  0.91  (0.73-1.13)  0.385      
Provinces            
Eastern Cape  0.83  (0.69-1.00)  0.054 1.27  (1.06-1.51)  0.167 
Northern Cape  1.41   (0.99-2.01)  0.054 1.61  (1.07-2.43)  0.065 
Western Cape  0.78  (0.69-0.88)  <0.001 1.17  (0.98-1.41)  0.081 
Free State  0.99  (0.77-1.26)  0.918      
Gauteng  0.97  (0.84-1.11)  0.630      
Mpumalanga  2.09  (1.49-2.92)  <0.001 1.67  (1.16-2.46)  0.007 
Limpopo  1.80  (1.40-2.32)  <0.001 1.60  (1.19-2.14)  0.002 
Kwa-Zulu Natal  0.85  (0.46-1.58)  0.603      
Northwest  1.78  (1.32-2.39)  <0.001 1.76  (1.25-2.48)  0.001 






Figure 1: Distribution of all Colorectal cancer and Adenocarcinoma of by Age Group in  







Figure 2: Anatomic Distribution of Colorectal Adenocarcinoma by Age Group in South 
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